The predicted inhibition and activation of upstream regulators ANXA2 and KDM5B, respectively, to target genes such as BAX, CDKN1A, GADD45A, and PBK further suggests that tumor growth is suppressed via p53-mediated processes [43]. The gene discussed is BAX; the disease is neoplasm.